Filtros de búsqueda

Lista de obras de Sunil S. Badve

A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer ⬇️

artículo científico publicado el 15 de marzo de 2012

An international study to increase concordance in Ki67 scoring

artículo científico publicado en 2015

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration

artículo científico publicado en 2016

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

scientific article published on 12 May 2020

Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer

artículo científico publicado en 2015

Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis

scientific article published on 03 December 2019

Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues ⬇️

artículo científico publicado el 25 de abril de 2011

Counterpoint: Cancer Stem Cells: Nonbelievers' Viewpoint ⬇️

artículo científico publicado el 7 de noviembre de 2012

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

artículo científico publicado en 2008

Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer

scientific article published on 05 August 2016

Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast

artículo científico publicado en 2010

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer

scientific article published on 26 March 2018

ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting

artículo científico

Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapy

artículo científico publicado en 2012

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer

artículo científico publicado en 2019

MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene

artículo científico publicado en 2017

Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast

scientific article published on 07 January 2021

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database

artículo científico publicado en 2017

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

artículo científico publicado en 2020

Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial

artículo científico publicado en 2013

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

artículo científico publicado en 2014

Prostanoid receptor EP1 expression in breast cancer

artículo científico publicado en 2007

Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer

artículo científico publicado en 2018

Reply to C. Shah et al.

artículo científico publicado en 2016

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

artículo científico publicado en 2020

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning

scholarly article by F Klauschen et al published October 2018 in Seminars in Cancer Biology

Splicing factor controls ER-positive breast cancer by altering metabolic pathways

artículo científico publicado en 2019

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

artículo científico publicado en 2015

TP53 Status and Estrogen Receptor-Beta in Triple-Negative Breast Cancer: Company Matters

scientific article published on 01 November 2019

The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance

artículo científico publicado en 2017

The Integrated Genomic Landscape of Thymic Epithelial Tumors

artículo científico publicado en 2018

The birth of an adenoid cystic carcinoma

artículo científico publicado en 2014

Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues

artículo científico publicado en 2019

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast

scientific article published in 2022

Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC).

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda